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Objective: The effect of a rat carotid endarterectomy (CEA) on homocysteine and the metabolic enzymes methylenetet-
rahydrofolate reductase (MTHFR) and cystathionine -synthase (CBS) was studied.
Methods: Rats were placed into 7 groups: (1) no anesthesia (NA), (2) anesthesia only (AO), (3) skin opened and closed
(O/C), (4) skin opened with exposure of the carotid artery and closed (O/E/C), (5) carotid isolated and clamped (CO),
(6) open CEA, and (7) open femoral endarterectomy (FEA). End points included homocysteine, hepatic MTHFR, and
CBS activity.
Results: Homocysteine in the NA, AO, O/C, O/E/C, and FEA were low and not different. CEA produced a 6-fold
increase in homocysteine when compared with non-CEA groups. Specifically, CEA produced an increase in homocysteine
versus the AO group at 2 weeks (11.3  0.7 vs 2.1  0.9 mol/L; P < .001), 4 weeks (8.9  0.7 vs 3.5  0.9 mol/L;
P .004) and 6 weeks (7.7 0.9 vs 3.1 1.5 mol/L; P .03). The CO group had increased homocysteine versus the
O/C, O/E/C, and FEA, but was lower than the CEA group. CEA produced an increase in MTHFR and CBS versus the
AO group.
Conclusions: CEA resulted in elevated levels of homocysteine; however, when broken down into its component parts, no
elevation was observed except for a small increase with the CO procedure. Manipulation of the femoral artery did not raise
homocysteine levels. The increase in homocysteine is possibly due to the combination of vessel wall damage and changes
in cerebral blood flow dynamics. ( J Vasc Surg 2004;40:796-803.)
Clinical Relevance: Our lab has identified increased plasma homocysteine, induced by diet modification, as a risk factor
in the development of intimal hyperplasia. To date, the effect of an operative procedure on plasma homocysteine has not
been evaluated. In this study, a carotid endarterectomy performed in the rat resulted in an elevation of plasma
homocysteine. If, as we have previously shown, elevated plasma homocysteine produces and “exaggerated” intimal
hyperplasia response after a vascular procedure, then the possibility that the operation itself can elevate homocysteine
levels could be clinically important. A patient who presents with a mild increase in homocysteine could advance to a
markedly elevated plasma level after undergoing a vascular operation. This elevation in plasma homocysteine could in turn
result in the formation of clinically relevant intimal hyperplasia that may negate the effect of the operation.Homocysteine is a sulfur-containing amino acid that is
formed during methionine metabolism.1 Hyperhomocys-
teinemia can be caused by several factors, including nutri-
tional deficiencies (folic acid, vitamins B6 and B12), and
enzyme abnormalities in 5,10-methylenetetrahydrofolate
reductase (MTHFR) and cystathionine -synthase
(CBS).2-4 Elevated plasma levels of homocysteine have
been reported to cause vascular injury and thrombosis in
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doi:10.1016/j.jvs.2004.07.011796animals and is an independent risk factor for coronary,
cerebral, and peripheral arterial occlusive disease.5-9 The
mechanisms involved in the atherogenic and thrombotic
complications of hyperhomocysteinemia are not under-
stood. It has been suggested that hyperhomocysteinemia
predisposes to atherosclerosis by injuring the vascular
endothelium.10 Homocysteine-induced vascular damage
may be multifactorial, including direct damage to endo-
thelium, stimulation of proliferation of smooth muscle
cells, increasing low-density lipoprotein peroxidation,
increase platelet aggregation, and effects on the coagu-
lation system.
Intimal hyperplasia affects nearly all manipulations of
the arterial tree and, as such, results in lowered patency
rates for vascular procedures.11-14 The effect of hyper-
homocysteinemia on postprocedure intimal hyperplasia
has not been well studied. Intimal hyperplasia has many
of the same pathologic and morphologic characteristics
of atherosclerosis, and thus hyperhomocysteinemia may
play an etiological role in its formation.15-20 We have
proposed that in the clinical setting of carotid endarter-
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“exaggerated” intimal hyperplasia response due to an
elevated homocysteine level.
In our rat studies using dietary modification to increase
plasma homocysteine levels,21,22 we observed that in-
creased plasma homocysteine combined with CEA resulted
in medial smooth muscle migration and proliferation pro-
ducing a significant increase in intimal hyperplasia and an
increase in luminal stenosis.
We have not found any literature regarding the effect of
an operative procedure alone on plasma homocysteine lev-
els. However, with increasing evidence that homocysteine
plays a role in atherosclerotic disease as well as postproce-
dural intimal hyperplasia, the effect of an acute operation
on homocysteine levels becomes important. The purpose
of this study was to evaluate the effect of a vascular opera-
tive procedure on plasma homocysteine levels. In addition,
if an increase was identified, then a breakdown of the
operation into its component parts would be undertaken to
evaluate which element was important in homocysteine
elevation.
METHODS
Animals. Male Sprague-Dawley rats weighing450 g
(Harlan Sprague-Dawley, Madison, Wis) were maintained
on standard lab chow (Teklad, Madison, Wis) and follow-
ing either treatment or operation were euthanized 2 weeks
later. Blood and liver tissue were removed for the measure-
ment of the following end points: plasma homocysteine,
red blood cell folate, and hepatic MTHFR and CBS en-
zyme activity. Groups were as follows: (1) no anesthesia
(NA) (n 5), (2) anesthesia only (AO) (2, 4, and 6 weeks;
n 4,3,3, respectively), (3) skin opened and closed (O/C)
(n 5), (4) skin opened with exposure of the carotid artery
and closed (O/E/C) (n  4), (5) carotid isolated and
clamped (CO) (n  5), (6) open CEA (2, 4, and 6 weeks;
n  5,5,5, respectively), and (7) open femoral endarterec-
tomy (FEA) (n  4).
Anesthesia. For the NA group, the rats were exposed
to CO2 until rendered unconscious and were then exsan-
guinated. The remainder of the groups that received anes-
thesia were given an ace promazine/ketamine (Fort
Dodge, Fort Dodge, Iowa; Phoenix Sci, St Joe, Mo) mix of
0.75 mL/0.1 kg body weight intraperitoneal. Food and
water were available ad libitum throughout the experimen-
tal period.
Surgery. In the O/C group, following a brief expo-
sure to isoflurane, rats were anesthetized and then prepped
for surgery. Using sterile technique and a dissecting micro-
scope (40 SZ40 Olympus; Olympus America Inc,
Melville, NY), a midline cervical incision was made and
then closed. The O/E/C group had the superficial muscles
divided and the dissection carried down to the level of the
left carotid artery. The cervical nerves in the region of the
artery were dissected free to preserve pharyngeal and esoph-
ageal functions and prevent postoperative respiratory com-
promise. Once the carotid was exposed, the wound was
immediately closed. In the CO group the carotid wasexposed and clamped by using Rumel tourniquets for a
period of 45 minutes (time required to complete an endar-
terectomy). In the CEA group the CEA surgery technique
previously published was used.21,22 Briefly, after adequate
carotid artery exposure, proximal and distal control at the
bifurcation, approximately 1.5 cm apart, was obtained by
using Rumel tourniquets fashioned from 3-0 silk suture
and #50 polyethylene tubing. Using a Beaver corneal
blade, an arteriotomy was made and extended to 6 mm in
length with micro-Potts scissors. Using a 27-gauge needle,
the intima was transversely scored across the vessel in 2
parallel lines, approximately 4 mm apart. The intima and
inner medial layer was removed with microforceps. The
arteriotomy was closed with a running 10-0 monofilament
nylon suture with a tapered 3/8 circle needle beginning at
the distal end. The distal Rumel tourniquet was slowly
removed first to assess for suture line hemostasis followed
by removal of the proximal Rumel tourniquet. Any suture
line bleeding was gently tamponaded with a sterile cotton-
tipped applicator until hemostasis was achieved. The end-
arterectomized carotid artery was assessed with a Doppler
scan to confirm patency. The superficial muscle layer was
closed with a running 3-0 Dexon suture and the skin closed
with interrupted suture. In the FEA group, the femoral
artery was exposed with a longitudinal groin incision and
the proximal and distal control was obtained on the femoral
artery using Rumel tourniquets. The artery was opened and
the intima removed, and the artery was closed in an iden-
tical fashion to the CEA group described earlier. The soft
tissue and skin were then closed. At 2 weeks post-surgery,
the O/C, CO, CEA, and FEA operated rats were anesthe-
tized and the carotid or femoral artery exposed. The abdo-
men was opened in the midline and the distal aorta and
inferior vena cava exposed. Blood was drawn from the
inferior vena cava for plasma homocysteine and folate anal-
yses. A portion of the liver was removed for enzyme activity
assays. (See the Table for a listing of groups.)
This study was approved by the VA Animal Care and
Use Committee, and animal care complied with the Na-
tional Research Council’s Guide for the Care and Use of
Laboratory Animals.
Plasma homocysteine measurements. All plasma ho-
mocysteine laboratory values were determined by the Clin-
ical Pathology Department at the Central Arkansas Veter-
ans Healthcare Facility, Little Rock, Ark. The plasma
homocysteine level was measured by using a thiol-specific
fluorogenic labeling reagent and the thiols were separated
by a reverse-phase high-pressure liquid chromatography
method using fluorescence detection.23
Serum folic acid measurements. Serum folate analy-
ses were determined by a [125I] rat folic acid RIA kit
(Diagnostic Products Corporation, Los Angeles, Calif).
Enzyme activity assays CBS. Livers were immediately
removed from the rats and frozen in liquid nitrogen until the
assay was performed. CBS activity was assayed by modification
of protocols by Mudd et al24 and Kraus.25 Briefly, liver tissue
was homogenized in 0.05 mol/L KH2PO4 (pH 7.5) and
centrifuged at 10,000  g at 4°C and the supernatant was
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Tris (pH 8.6), 1 mmol/L pyridoxal phosphate, 0.7 mg cellu-
lar protein extract, 0.5 mg/mL bovine serum albumin, 0.06
Ci 14C-serine, 10 mmol/L serine, 15 mmol/L L-homocys-
teine, and 1 mmol/L cystathionine. The reaction mixture was
incubated for 3 hours at 37°C, during which time the 14C-
serine was converted by CBS into 14C-cystathionine. The
14C-cystathionine was separated from 14C-serine by ascend-
ing paper chromatography using 2-propanol/formic
acid/water (80:6:20) v/v as the mobile phase. The 14C-
cystathionine was cut out and counted in scintillation fluid.
We defined 1 unit of enzyme activity as that which formed one
nmol of cystathionine per hour at 37°C. Enzyme specific
activity was expressed as units/mg of cellular protein. Protein
was determined using the BioRad protein reagent.
Methylenetetrahydrofolate reductase. The MTHFR
activity assay was modified from the procedure by Mudd
et al.26 The liver tissue was homogenized in 0.25 mol/L
sucrose, centrifuged at 50,000  g for 1 hour and the
supernatant was collected. The enzyme reaction mixture
contained the following: 0.18 mol/L KH2PO4 (pH
6.3), 3.6 mM menadione bisulfite, 1.4 mmol/L EDTA,
7.2 mmol/L ascorbic acid, 178 mol/L flavin adenine
dinucleotide and 420 mol/L of 14C-5-methyltetrahy-
drofolate. The reaction mix was incubated for 1 hour at
37°C, and then terminated by the addition of 0.6 mol/L
sodium acetate pH 4.5, 0.1 mol/L formaldehyde, and
0.4 mol/L dimedone (5,5 dimethyl-1,3-cyclohexanedi-
one) in 50% ethanol. The samples were boiled, toluene
was added, and 2 mL of the upper phase containing
14C-formaldehyde was removed for counting in scintil-
lation fluid. The enzyme activity was expressed as
nmol/h formed per mg of protein.
Statistics. Data was analyzed as means  SE by anal-
ysis of variance and simple regression analysis, using the
StatView for Windows Program, Version 5.0 (SAS Institute
Inc. 1992-98).
RESULTS
Plasma homocysteine measured in rats receiving NA or
AO was low and consistent with published data for a
normal homocysteine value in a rat (Fig 1). Plasma homo-
cysteine in rats 2 weeks after undergoing NA, AO, O/C,
and O/E/C procedures were low and did not show any




Group 2 Isoflurane/ketamine-ace promazine
Group 3 Isoflurane/ketamine-ace promazine
Group 4 Isoflurane/ketamine-ace promazine
Group 5 Isoflurane/ketamine-ace promazine
Group 6 Isoflurane/ketamine-ace promazine
Group 7 Isoflurane/ketamine-ace promazine
NA, No anesthesia; AO, anesthesia only; O/C, open/closure of skin; O/E/C
femoral endarterectomy.also had low plasma homocysteine levels measured at 2
weeks post-procedure (Fig 1). Rats undergoing a CEA
procedure showed a nearly 6-fold increase in plasma homo-
cysteine at 2 weeks post-CEA when compared to non-CEA
groups (Fig 1). The CO rats exhibited an approximate
doubling of plasma homocysteine versus the O/C,
O/E/C, and FEA groups at P .05 (4.1 0.6 CO vs 0.9
 0.5, 1.8  0.5, 2.0  1.1, respectively). Plasma homo-
cysteine levels in the CO group were elevated; however,
they did not reach statistical significance compared with the
AO and NA groups (P  .07). This small increase in the
CO group was significantly less than the large increase seen
in the CEA group (P  .0001). The increase in plasma
homocysteine in the CEA group remained significant for
up to 6 weeks post-CEA (Fig 1). At the 4- and 6-week
post-CEA time points, plasma homocysteine concentra-
tions in rats undergoing CEA increased 2 to 3 times com-
pared with AO rats.
Red blood cell (RBC) folate analyses of CEA and AO
rats demonstrated a positive correlation between plasma
homocysteine concentrations and RBC folate at P  .005,
r  .62 (Fig 2).
The CEA procedure produced an increase in MTHFR
and CBS enzyme activity at 2, 4, and 6 weeks post-CEA as
compared to enzyme levels measured in AO rats. This
4-fold increase in MTHFR (Fig 3) and nearly 50% increase
in CBS activity (Fig 4) was observed at 2 weeks post-CEA
and remained at these elevated values for the duration of
the 6-week experimental protocol. Folate, a cofactor for
MTHFR in the remethylation pathway of homocysteine to
methionine, was positively correlated with MTHFR activity
(P  .0003; r  .73) (Fig 5).
DISCUSSION
There are few reports examining plasma homocysteine
levels after major vascular events and none describing the
effect of a vascular procedure on these levels. We observed
that, after a vascular surgical procedure to the rat carotid
artery, measurable increases in plasma homocysteine were
detected. This increase in plasma homocysteine seen at 2
weeks after a CEA was not duplicated after a femoral
endarterectomy. Clamping the carotid artery alone pro-
duced a doubling of the homocysteine level versus other
control groups except for NA and AO groups. While this
small increase was observed, it was significantly less than the
Procedure Blood and tissue sampled
None, NA Immediate
None, AO Immediate, 2, 4, and 6 weeks
O/C 2 weeks postprocedure
O/E/C 2 weeks postprocedure
CO 2 weeks postprocedure
CEA 2, 4, and 6 weeks postprocedure
FEA 2 weeks postprocedure
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Perhaps significance was not quite reached versus the AO
and NA groups due to the low numbers in each group (n
5). No increase was observed when the components of the
Fig 1. Plasma homocysteine between groups over time. Homo-
cysteine levels in no anesthesia (NA) compared with anesthesia
only (AO) indicate low levels compatible with control rats and no
differences between these groups. With the carotid endarterec-
tomy (CEA) there was a significant increase in plasma homocys-
teine at P .01 compared with all groups, including NA, AO, skin
incision groups open/close (OC) and open/expose carotid/close
(O/E/C), rats that received a femoral endarterectomy (FEA), and
a clamp-only (CO) group. The increase in homocysteine concen-
tration that was observed with CEA remained at 4 and 6 weeks.
The CO group had a significant increase over other non-CEA
groups except for the NA and AO group. Means are SEM.
*Indicates CEA group means P  .05 versus all other treatment
groups. t Indicates CO group means P .05 versus O/C, O/E/C,
and FEA.
Fig 2. Positive correlation of plasma homocysteine and red blood
cell folate. Regression analysis between plasma homocysteine and
corresponding red blood cells indicate a significant correlation.operative procedure were broken down into their respec-
tive parts and evaluated individually, except for the CO
group. This study indicates that anesthetic alone, surgical
dissection, and manipulation of the intima within the artery
are not the prime etiological factors in producing the
elevated homocysteine level. It appears that the carotid
artery itself needs to be clamped and the intima removed to
produce a significant 6-fold increase in plasma homocys-
teine. The relative contribution of these few factors is
difficult to determine since it is obviously impossible to
Fig 3. Hepatic MTHFR enzyme activity compared between ca-
rotid endarterectomy (CEA) operated and anesthesia only (AO).
The stimulative response of the CEA injury produced an overall
increase in nmol/h of enzyme activity for MTHFR, indicating an
increase in remethylation in the homocysteine metabolism path-
way. Means are SEM. *Indicates P  .05.
Fig 4. Hepatic cystathionine -synthase (CBS) enzyme activity
compared between carotid endarterectomy (CEA) operated and
anesthesia only (AO). The stimulative response of the CEA injury
produced an overall increase in U/mg of enzyme activity for CBS,
indicating an increase in the transsulfuration pathway in homocys-
teine metabolism. Means are SEM. *Indicates P  .05.
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ever, it appears that a portion of the increase in homocys-
teine levels can be attributed to a carotid clamp. Clamping
of the femoral artery, even with intima removal, does not
produce an elevation in plasma homocysteine. In addition,
the post-CEA elevation persisted for the duration of our
observation period, a full 6-weeks post-CEA. The results
lead us to speculate that perhaps cerebral-flow dynamic
changes at time of the carotid occlusion coupled with vessel
wall and intima disruption or trauma may be the etiological
factor in the elevation in homocysteine concentrations fol-
lowing a CEA, since in the experimental design these were
the only elements in the operative protocol that could
independently be shown to increase plasma homocysteine
levels. This would also explain the lack of increased homo-
cysteine in the FEA group. The change in cerebral flow
dynamics could be a trigger for the activation of a metabolic
process that may progress through a number of steps that
eventually lead to hyperhomocysteinemia. This trigger and
process appear not to be transient in that increased homo-
cysteine is observed as far as 6 weeks post-CEA. Obviously,
this is pure speculation and the study did not involve an
assessment of cerebral blood flow dynamics.
A few clinical studies have demonstrated an increase in
plasma homocysteine levels in different clinical settings of
either cerebral or myocardial flow changes or damage.
Howard et al27 performed serial measurements in patients
during the acute phase of a stroke. However, there was no
evidence of stroke or symptoms of stroke with the increase
in plasma homocysteine in our study. Howard et al27
observed a pattern of increasing homocysteine concentra-
tions during the first 2 weeks, with levels peaking at 10 to
14 days (11.3 0.5 vs 13.7 0.7, P .0001). Meiklejohn
et al28 also measured plasma homocysteine concentrations
Fig 5. Positive correlation of hepatic MTHFR and folate levels.
Folate, a co-factor for MTHFR in the homocysteine metabolism
pathway, was positively correlated with levels of MTHFR, indicat-
ing that endarterectomy surgical stress induced a hepatic change
that altered metabolic enzymes as well as folate levels.in stroke patients within 4 days, with a second measurement
between 68 to 270 days. Their results indicated no differ-
ence at the early measurement; however, measurements
between 68 to 270 days were found to be significant above
age-matched controls (women 8.1 vs 10.0 mol/L; men
9.2 vs 10.2 mol/L). This indicates that length of time
post-trauma event may be a factor in determining plasma
homocysteine levels. Egerton et al29 performed serial mea-
surements of plasma homocysteine following an acute myo-
cardial infarction. Measurements were performed on days
1, 3, and 7 and 3 weeks and 6 months after hospital
admission. Their results indicate a significant peak increase
in homocysteine concentration at day 7, which decreased
by 21 days (18.7  1.6 vs 16.8  1.6 mol/L, P  .05).
We have observed that intimal hyperplasia after CEA is
increased in the setting of diet induced hyperhomocys-
teinemia.22 Damage to the carotid artery intima itself ap-
pears to result in an increase in homocysteine. Perhaps the
increase in homocysteine in this study is part of a natural
mechanism for repair of the arterial damage. While intimal
hyperplasia can result in an untoward and unwanted clinical
effect, the intimal hyperplasia response can be viewed as a
mechanism by which the damaged and absent intima is
replaced. The lack of this reparative response mechanism with
FEA is unclear. Perhaps it is not observed because of the lack
of synergistic effect of changes in cerebral blood flow.
Increased circulation of homocysteine has a profound
effect on cell proliferation; studies of vascular smooth mus-
cle cell culture systems show that homocysteine addition to
the culture medium induces cell proliferation,30 TIMP-1,
tPA, MMP,31 protein kinase C activation,32 nitric oxide
synthesis,33 proto-oncogene expression, diacylglycerol ac-
tivation32 and DNA synthesis shown by thymidine incor-
poration.34 Homocysteine stimulation of these factors can
induce cell growth by contributing to smooth muscle mi-
gration and proliferation which are the hallmark of intimal
hyperplasia and thus lead to restenosis.
In this study, the CEA may also be considered as a
stimulating factor in altering folate levels and disrupting
hepatic MTHFR and CBS activity. It is interesting to
speculate that change in cerebral hemodynamics resulting
from the occlusion of the carotid artery during the endar-
terectomy and/or intimal damage may have induced an
increase of stress or inflammation and therefore an altered
hepatic metabolic response. Systemic changes that can oc-
cur with acute stress or illnesses such as increases in hepatic
proteins (ie, increased synthesis of C-reactive proteins and
serum amyloid A35). The liver, as the primary site of homo-
cysteine metabolism, may have responded to the increase in
stress and altered its metabolism of homocysteine by shift-
ing from remethylation to the transsulfuration route to
remove excess homocysteine from the system.
To our knowledge, no other study has examined
plasma homocysteine levels before and after surgery. How-
ever, there are numerous clinical studies of the B vitamins
that are cofactors for homocysteine metabolism (folate and
vitamins B6 and B12) decreasing plasma homocysteine
concentrations. This would suggest a negative correlation
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study, we observed a strong positive correlation of plasma
folate and homocysteine. We can only conjecture that this
observation may be due to the hepatic system attempting to
compensate for the transitory increase in plasma homocys-
teine. Torres and co-workers36 were the first to indicate a
connection between the effects with plasma homocysteine
in the vasculature and the liver. They observed in human
vascular smooth muscle cell cultures and hepatocyte cell
cultures that homocysteine stimulated production of tissue
inhibitor of metalloproteinases-1 (TIMP-1) and 1(I) pro-
collagen expression, suggesting that elevated plasma ho-
mocysteine may participate in the pathogenesis of liver
fibrosis as well as peripheral vascular disease. Heretofore,
there are no studies examining the influence of stress as a
factor, in response to surgical trauma on blood levels of
homocysteine. However, there have been studies that have
reported increased homocysteine levels in women placed in
acute psychologically stressful situations.37
This study suggests that a CEA procedure can produce
a significant and sustained increase with homocysteine.
This increase in homocysteine has been shown to result
with an increased intimal hyperplasia response, thus linking
these 2 events. In addition, this study suggests that if
hyperhomocysteinemia is an issue with the clinical care of a
patient, it must be evaluated postoperatively and for some
extended time after, and, if elevated, this treatment must
continue in the postoperative period.
In conclusion, vascular intima manipulation in which
cerebral blood flow change is a factor may induce a plasma
homocysteine elevation resulting in an adaptive increase in
activity of hepatic metabolic enzymes.
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